inSoma Bio develops recombinant protein-based materials that mimic natural human proteins to create bio-compatible scaffolds for tissue engineering. Their Fractomer biomatrix technology enables the use of a patient's own tissue in reconstructive surgeries, eliminating the need for synthetic implants and enhancing biointegration.
Funding
$5.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CAFounders
Product
Problem
Current reconstructive surgeries often rely on synthetic implants and fillers, which can lead to biocompatibility issues and suboptimal tissue integration. These synthetic materials may not fully support the body's natural healing processes, potentially resulting in complications and less-than-ideal aesthetic outcomes.
Solution
inSoma Bio develops recombinant protein-based biomaterials, called Fractomers, designed to mimic the structure and function of natural human proteins. These bio-compatible scaffolds support the body's own cells and tissues during reconstructive procedures, promoting enhanced biointegration and tissue regeneration. The Fractomer biomatrix technology enables surgeons to utilize a patient's own tissue, reducing the need for synthetic materials and minimizing the risk of adverse reactions. Fractomers provide structural support and shape, while also facilitating the integration of co-injected cells or tissues. The materials are activated by body temperature, ensuring they function effectively within the surgical site.
Target Audience
The primary target audience includes reconstructive surgeons, plastic surgeons, and hospitals seeking advanced biomaterials for improved surgical outcomes and enhanced patient recovery.
Features
- Recombinant protein-based materials that mimic natural human proteins
- Thermally activated biomatrix that supports tissue regeneration at body temperature
- Enhanced biointegration of patient's own tissue, reducing reliance on synthetic materials
- Customizable scaffolds for various reconstructive surgery applications
- Designed at the genetic level and produced without the need to harvest natural tissue